Dr. Shuibing Chen is the Kilts Family Associate Professor and the Director of Diabetes Program in the Department of Surgery at Weill Cornell Medicine, New York. She received my B.S. and M.S. in Chemistry from Tsinghua University in China. Then, she pursued my PhD under the advisement of Dr. Peter G. Schultz at the Scripps Research Institute. After graduation, she joined Dr. Doug Melton’s laboratory at Harvard University to study the directed differentiation of human embryonic stem cells toward pancreatic lineage.

The major research interest in the Chen Laboratory at Weill Cornell Medicine focuses on studying the role of genetic factors and environmental factors on pancreatic beta cell in type 1 and 2 diabetes. In response to the COVID-19 pandemic, Dr. Chen created a panel of hPSC-derived cells/organoids to study SARS-CoV-2 infection. Dr, Chen has published more than 40 papers on peer-reviewed high impact journals, such as Nature, Nature Medicine, Cell Metabolism, Cell Stem Cell, Circulation Research, Nature Chemical Biology, etc. She has received many awards including New York Stem Cell Foundation Robertson Investigator, American Diabetes Association (ADA) Junior Faculty Award, ADA Innovative Award, NIH Director’s New Innovator Award, American Association for Cancer Research Career Development Award, and ISSCR Dr. Susan Lim Award for Outstanding Young Investigator, etc.